Skip to main content

Nautilus Advisors LLC

SEC CIK
0002083253
Latest filing
Jul 14, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Nautilus Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2025)
0
Sold out in Q2 2025
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q4 2024
Holdings of REGN by Nautilus Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20250$00.0%−333−100.0%Sold outHolders
Q1 2025333$211.2K0.2%+35+11.7%AddedHolders
Q4 2024298$212.3K0.2%–No prior filingHolders